| 5-Hydroxyeicosatetraenoic acid: 5-Hydroxyeicosatetraenoic acid kahi eicosanoid, ʻo ia kahi metabolite o ka waikawa arachidonic. Hana ʻia ia e nā ʻano pūnaewele like ʻole i loko o nā kānaka a me nā ʻano holoholona ʻē aʻe. Hiki i kēia mau hunaola ke hoʻopili i ka 5 ( S ) -HETE i 5-oxo-eicosatetraenoic acid (5-oxo-ETE), 5 ( S ), 15 ( S ) -dihydroxyeicosatetraenoic acid, a i ʻole 5-oxo-15-hydroxyeicosatetraenoic acid . | |
| 5-Hydroxyferulic acid: ʻO ka 5-Hydroxyferulic acid kahi waikawa hydroxycinnamic. | |
| 5-Hydroxyhydantoin: ʻO 5-Hydroxyhydantoin kahi huahana hoʻoheheʻe o 2′-deoxycytidine. Inā ʻaʻole i hoʻoponopono ʻia, hana ʻia paha e DNA polymerases e hoʻohuli i nā hana mutagenic. | |
| 5-Hydroxyeicosatetraenoic acid: 5-Hydroxyeicosatetraenoic acid kahi eicosanoid, ʻo ia kahi metabolite o ka waikawa arachidonic. Hana ʻia ia e nā ʻano pūnaewele like ʻole i loko o nā kānaka a me nā ʻano holoholona ʻē aʻe. Hiki i kēia mau hunaola ke hoʻopili i ka 5 ( S ) -HETE i 5-oxo-eicosatetraenoic acid (5-oxo-ETE), 5 ( S ), 15 ( S ) -dihydroxyeicosatetraenoic acid, a i ʻole 5-oxo-15-hydroxyeicosatetraenoic acid . | |
| 5-Hydroxyeicosatetraenoic acid: 5-Hydroxyeicosatetraenoic acid kahi eicosanoid, ʻo ia kahi metabolite o ka waikawa arachidonic. Hana ʻia ia e nā ʻano pūnaewele like ʻole i loko o nā kānaka a me nā ʻano holoholona ʻē aʻe. Hiki i kēia mau hunaola ke hoʻopili i ka 5 ( S ) -HETE i 5-oxo-eicosatetraenoic acid (5-oxo-ETE), 5 ( S ), 15 ( S ) -dihydroxyeicosatetraenoic acid, a i ʻole 5-oxo-15-hydroxyeicosatetraenoic acid . | |
| 5-Hydroxyindoleacetic acid: 5-Hydroxyindoleacetic acid (5-HIAA) ka metabolite nui o ka serotonin. I ke kālailai kemika o nā mimi, hoʻohana ʻia ʻo 5-HIAA e hoʻoholo i nā pae serotonin i loko o ke kino. | |
| 5-Hydroxyindoleacetic acid: 5-Hydroxyindoleacetic acid (5-HIAA) ka metabolite nui o ka serotonin. I ke kālailai kemika o nā mimi, hoʻohana ʻia ʻo 5-HIAA e hoʻoholo i nā pae serotonin i loko o ke kino. | |
| 5-Hydroxyisourate: ʻO 5-Hydroxyisourate kahi molekiola me kahi kūmole o C 5 H 4 N 4 O 4 a me ke kaupaona o 184.110 g / mol. ʻO ia ka huahana o ka oxidation o uric acid e urate oxidase. | |
| 5-Hydroxymaltol: ʻO 5-Hydroxymaltol , kahi mea loaʻa o maltol, kahi mea i loaʻa ma Penicillium echinulatum . ʻIke ʻia ia i ka lāʻau ʻoka i hoʻomoʻa ʻia a me nā honeys mai ka polu polū a me ka pahu melemele. | |
| Hydroxymethylfurfural: ʻO Hydroxymethylfurfural (HMF), ʻo 5- (hydroxymethyl) furfural, kahi hui kūlohelohe i hoʻokumu ʻia e ka dehydration o ka hōʻemi ʻana i nā kō. He paʻa keʻokeʻo haʻahaʻa hoʻoheheʻe keʻokeʻo ia i hiki ke hoʻonā ʻia i nā wai a me nā mea hoʻoheheʻe kūlohelohe. Aia ka mole i ke apo furan, i loko o nā hui ʻelua aldehyde a me nā mea ʻona. | |
| 5-Hydroxymethylcytosine: 5-Hydroxymethylcytosine (5hmC) kahi DNA pyrimidine nitrogen base i loaʻa mai ka cytosine. He mea nui paha ia i nā epigenetics, no ka mea hiki i ka hui hydroxymethyl ma ka cytosine ke hoʻololi i kahi ʻāpana a pio. ʻIke mua ʻia ia i nā bacteriophages i ka makahiki 1952. Eia nō naʻe, i ka makahiki 2009 ua ʻike ʻia ka nui o ka lolo kanaka a me ka ʻiole, a me nā pūpū kūmoa embryonic. I nā māmela, hiki ke hana ʻia e ka hoʻōla o 5-methylcytosine, kahi hopena i hoʻopili ʻia e nā ʻenekini TET. ʻO C 5 H 7 N 3 O 2 ke ʻano o kona molaki . | |
| Hydroxymethylfurfural: ʻO Hydroxymethylfurfural (HMF), ʻo 5- (hydroxymethyl) furfural, kahi hui kūlohelohe i hoʻokumu ʻia e ka dehydration o ka hōʻemi ʻana i nā kō. He paʻa keʻokeʻo haʻahaʻa hoʻoheheʻe keʻokeʻo ia i hiki ke hoʻonā ʻia i nā wai a me nā mea hoʻoheheʻe kūlohelohe. Aia ka mole i ke apo furan, i loko o nā hui ʻelua aldehyde a me nā mea ʻona. | |
| ʻO Juglone: ʻO Juglone , i kapa ʻia hoʻi ʻo 5-hydroxy-1,4-naphthalenedione (IUPAC) kahi hui kūmole me ka mole mole C 10 H 6 O 3 . I ka ʻoihana meaʻai, ʻike ʻia ka juglone ʻo CI Natural Brown 7 a me CI 75500 . He ʻole ia i ka benzene akā hiki ke hoʻoheheʻe ʻia i ka dioxane, kahi e crystallize ai ʻo ia e like me nā nila melemele. He isomer ʻo ia o ka lawone, ʻo ia ka hui pū ʻia i ka lau henna. | |
| Serotonin: ʻO Serotonin a i ʻole 5-hydroxytr Egyptamine ( 5-HT ) kahi neurotransmitter monoamine. He paʻakikī a multifaceted kāna hana biology, hoʻololi i ka naʻau, ʻike, uku, aʻo, hoʻomanaʻo, a me nā hanana physiological e like me ka luaʻi a me ka vasoconstriction. | |
| ʻO 5-HT ka mea loaʻa: ʻO nā mea loaʻa ʻo 5-HT , nā mea loaʻa he 5-hydroxytr Egyptamine , a i ʻole nā mea loaʻa serotonin , kahi hui o nā mea loaʻa pū kekahi protein G a me nā kaha ion ligand-gated i loaʻa i nā ʻōnaehana kikowaena a me nā ʻaoʻao āpau. Hoʻopili lākou i nā neurotransmission excitatory a me inhibitory. Hoʻoulu ʻia nā mea hoʻolauna serotonin e ka neurotransmitter serotonin, e hana nei ma ke ʻano he ligand maoli. | |
| 5-Hydroxytr Egyptophan: ʻO 5-Hydroxytr Egyptophan ( 5-HTP ), a i ʻike ʻia he oxitriptan , kahi amino acid a me ka precursor kemika e kū nei a me kahi interabate metabolic i ka biosynthesis o ka serotonin neurotransmitter. | |
| 5-Hydroxyuracil: ʻO 5-Hydroxyuracil kahi ʻano oxidized o cytosine e hana ʻia e ka deidation oxidative o cytosines e nā ʻano oxygen o ka reactive. ʻAʻole ia e kekeʻe i ka mole mole DNA a kāpae ʻia e nā polymerases DNA replicative. Hiki iā miscode no ka adenine a he mutagenic paha ia. | |
| 5I: 5I a i ʻole 5- Hiki iaʻu ke kuhikuhi iā:
| |
| 5-I-R91150: 5-I-R91150 kahi hui e hana ma ke ʻano he antagonist ikaika a koho ʻia o nā mea loaʻa ʻo 5-HT 2A . ʻO kāna noi nui e like me kona ʻano iodine-123 radiolabeled, kahi e hiki ai ke hoʻohana ʻia i ka nānā ʻana o SPECT i nā noi neuroimaging kanaka, e nānā ai i ka hāʻawi ʻana o ka subtype 5-HT 2A i ka lolo, e pili ana i ka moekolohe a me nā makahiki a me i nā mākua me ka maʻi Asperger a i ʻole ka maʻi ʻo Alzheimer. | |
| 5-IAI: ʻO 5-Iodo-2-aminoindane ( 5-IAI ) kahi lāʻau i hana ma ke ʻano he hoʻokuʻu hoʻokuʻu o serotonin, norepinephrine, a me dopamine. Ua hoʻomohala ʻia i nā makahiki 1990 e kahi hui i alakaʻi ʻia e David E. Nichols ma ke Kulanui ʻo Purdue. Hoʻololi piha ʻo 5-IAI iā MDMA i nā meheu a me kahi entactogen putative i loko o nā kānaka. ʻAʻole like me nā mea aminoindane e pili ana e like me MDAI a me MMAI, 5-IAI ke kumu o kekahi serotonergic neurotoxicity i nāʻiole, akā ʻoi aku ka liʻiliʻi o ka lāʻau ʻona ma mua o kāna amphetamine homologue pIA, me nā ʻino i ʻike ʻia ʻaʻole hiki i ka helu helu. | |
| 5-IT: 5- (2-Aminopropyl) indole kahi indole a me ka phenethylamine derivative me nā hopena emphogenic. Ua hōʻike mua ʻia kāna hoʻomākaukau e Albert Hofmann i ka makahiki 1962. He lāʻau lapaʻau hoʻolālā kēlā i kūʻai ākea ʻia ma ke ʻano he lāʻau leʻaleʻa e nā mea kūʻai aku ma ka pūnaewele mai 2011. | |
| 5-Inch i mua o ka lele ʻana i nā mokulele mokulele: ʻO ka 5-inch Forward Firing Aircraft Rocket a i ʻole FFAR he rocket ʻAmelika i hoʻomohala ʻia i ka wā o ke Kaua Honua II no ka hoʻouka kaua ʻana mai nā mokulele e kūʻē i nā pae honua a me nā moku. | |
| 5-Inch i mua o ka lele ʻana i nā mokulele mokulele: ʻO ka 5-inch Forward Firing Aircraft Rocket a i ʻole FFAR he rocket ʻAmelika i hoʻomohala ʻia i ka wā o ke Kaua Honua II no ka hoʻouka kaua ʻana mai nā mokulele e kūʻē i nā pae honua a me nā moku. | |
| 5-APDI: 5- (2-Aminopropyl) -2,3-dihydro-1 H -indene ( 5-APDI ), ʻike ʻia ʻo indanylaminopropane ( IAP ), IAP (psychedelic), 2-API (2-aminopropylindane), indanametamine, a me pololei ʻole , ma ke ʻano indanylamphetamine , he entactogen a me ka lāʻau psychedelic o ka ʻohana amphetamine. Ua kūʻai ʻia aku e nā mea kūʻai aku ma ka pūnaewele ma o ka Pūnaewele a ua ʻike ʻia ma ke ʻano he lāʻau hoʻolālā mai ka makahiki 2003, akā ua hoʻemi ʻia kona kaulana a me kona loaʻa i nā makahiki i hala iho nei. | |
| 5-IAI: ʻO 5-Iodo-2-aminoindane ( 5-IAI ) kahi lāʻau i hana ma ke ʻano he hoʻokuʻu hoʻokuʻu o serotonin, norepinephrine, a me dopamine. Ua hoʻomohala ʻia i nā makahiki 1990 e kahi hui i alakaʻi ʻia e David E. Nichols ma ke Kulanui ʻo Purdue. Hoʻololi piha ʻo 5-IAI iā MDMA i nā meheu a me kahi entactogen putative i loko o nā kānaka. ʻAʻole like me nā mea aminoindane e pili ana e like me MDAI a me MMAI, 5-IAI ke kumu o kekahi serotonergic neurotoxicity i nāʻiole, akā ʻoi aku ka liʻiliʻi o ka lāʻau ʻona ma mua o kāna amphetamine homologue pIA, me nā ʻino i ʻike ʻia ʻaʻole hiki i ka helu helu. | |
| 5-IAI: ʻO 5-Iodo-2-aminoindane ( 5-IAI ) kahi lāʻau i hana ma ke ʻano he hoʻokuʻu hoʻokuʻu o serotonin, norepinephrine, a me dopamine. Ua hoʻomohala ʻia i nā makahiki 1990 e kahi hui i alakaʻi ʻia e David E. Nichols ma ke Kulanui ʻo Purdue. Hoʻololi piha ʻo 5-IAI iā MDMA i nā meheu a me kahi entactogen putative i loko o nā kānaka. ʻAʻole like me nā mea aminoindane e pili ana e like me MDAI a me MMAI, 5-IAI ke kumu o kekahi serotonergic neurotoxicity i nāʻiole, akā ʻoi aku ka liʻiliʻi o ka lāʻau ʻona ma mua o kāna amphetamine homologue pIA, me nā ʻino i ʻike ʻia ʻaʻole hiki i ka helu helu. | |
| 5-IAI: ʻO 5-Iodo-2-aminoindane ( 5-IAI ) kahi lāʻau i hana ma ke ʻano he hoʻokuʻu hoʻokuʻu o serotonin, norepinephrine, a me dopamine. Ua hoʻomohala ʻia i nā makahiki 1990 e kahi hui i alakaʻi ʻia e David E. Nichols ma ke Kulanui ʻo Purdue. Hoʻololi piha ʻo 5-IAI iā MDMA i nā meheu a me kahi entactogen putative i loko o nā kānaka. ʻAʻole like me nā mea aminoindane e pili ana e like me MDAI a me MMAI, 5-IAI ke kumu o kekahi serotonergic neurotoxicity i nāʻiole, akā ʻoi aku ka liʻiliʻi o ka lāʻau ʻona ma mua o kāna amphetamine homologue pIA, me nā ʻino i ʻike ʻia ʻaʻole hiki i ka helu helu. | |
| 5-Iodowillardiine: ʻO 5-Iodowillardiine kahi agonist koho no ka reseptor kainate, me nā hopena palena wale nō ma ka AMPA receptor. He wae ia no nā mea lawe lole kainate i haku ʻia o nā subunits GluR5. He neurotoxin excitotoxic ia i loko o vivo , akā ua hōʻoia maikaʻi loa ia no ka hōʻike ʻana i nā subtypes a me ka hana o nā mea loaʻa nā kainate ʻokoʻa i ka lolo a me ka iwi kuamoo. | |
| 5J: E kuhikuhi paha ʻo 5J a i ʻole 5-J iā:
| |
| 5K: E nānā paha ʻo 5K a i ʻole 5-K i:
| |
| Holo ʻo 5K: ʻO ka holo 5K kahi hoʻokūkū holo mamao e holo ana ma kahi o ʻelima mau mile (3.107 mi). Kapa ʻia ʻo ka heihei alanui 5K , 5 km , a i ʻole 5K maʻalahi, ʻo ia ka pōkole loa o ke ala maʻamau e holo nei i nā mamao. Hoʻomaʻamaʻa mau ʻia ia mai ka hanana holo mika 5000 mika ma ka haʻi ʻana i ka mamao i nā mile, ma mua o nā mika. | |
| 5L: Hiki iā 5L a i ʻole 5-L ke kuhikuhi i: | |
| Arachidonate 5-lipoxygenase: ʻO Arachidonate 5-lipoxygenase , a i kapa ʻia hoʻi me ALOX5 , 5-lipoxygenase , 5-LOX , a i ʻole 5-LO , kahi enzyme non-heme iron-i loaʻa i loko o nā kānaka e ka encode ALOX5 . ʻO Arachidonate 5-lipoxygenase kahi lālā o ka ʻohana lipoxygenase o nā enzymes. Hoʻololi ia i nā mea momona momona (EFA) substrates i loko o nā leukotrienes a me ka laulā o nā huahana biologically ʻeleu. ʻO ALOX5 kahi pahuhopu i kēia manawa no ka hoʻopili lāʻau i loko o nā ʻano maʻi. | |
| Arachidonate 5-lipoxygenase: ʻO Arachidonate 5-lipoxygenase , a i kapa ʻia hoʻi me ALOX5 , 5-lipoxygenase , 5-LOX , a i ʻole 5-LO , kahi enzyme non-heme iron-i loaʻa i loko o nā kānaka e ka encode ALOX5 . ʻO Arachidonate 5-lipoxygenase kahi lālā o ka ʻohana lipoxygenase o nā enzymes. Hoʻololi ia i nā mea momona momona (EFA) substrates i loko o nā leukotrienes a me ka laulā o nā huahana biologically ʻeleu. ʻO ALOX5 kahi pahuhopu i kēia manawa no ka hoʻopili lāʻau i loko o nā ʻano maʻi. | |
| Hoʻolālā Arachidonate 5-lipoxygenase: ʻO nā mea hoʻopili ʻo Arachidonate 5-lipoxygenase nā mea hoʻohui e hoʻolohi a hoʻopaʻa paha i ka hana o ka arachidonate 5-lipoxygenase enzyme, ʻo ia ke kuleana no ka hana ʻana i nā leukotrienes inflammatory. ʻO ka overproduction o leukotrienes kahi kumu nui o ka mumū i ka hānō, ka maʻi maʻi a me ka osteoarthritis. | |
| Arachidonate 5-lipoxygenase: ʻO Arachidonate 5-lipoxygenase , a i kapa ʻia hoʻi me ALOX5 , 5-lipoxygenase , 5-LOX , a i ʻole 5-LO , kahi enzyme non-heme iron-i loaʻa i loko o nā kānaka e ka encode ALOX5 . ʻO Arachidonate 5-lipoxygenase kahi lālā o ka ʻohana lipoxygenase o nā enzymes. Hoʻololi ia i nā mea momona momona (EFA) substrates i loko o nā leukotrienes a me ka laulā o nā huahana biologically ʻeleu. ʻO ALOX5 kahi pahuhopu i kēia manawa no ka hoʻopili lāʻau i loko o nā ʻano maʻi. | |
| 5 (Ka lawelawe ʻo Subway City New York): ʻO ka 5 Lexington Avenue Express kahi lawelawe wikiwiki i ka A Division o ka New York City Subway. ʻO kāna peʻa ala, a i ʻole "pōkā", ʻōmaʻomaʻo ʻōpala mai ka hoʻohana ʻana i ka IRT Lexington Avenue Line ma Manhattan | |
| 5 (Ka lawelawe ʻo Subway City New York): ʻO ka 5 Lexington Avenue Express kahi lawelawe wikiwiki i ka A Division o ka New York City Subway. ʻO kāna peʻa ala, a i ʻole "pōkā", ʻōmaʻomaʻo ʻōpala mai ka hoʻohana ʻana i ka IRT Lexington Avenue Line ma Manhattan | |
| Arachidonate 5-lipoxygenase: ʻO Arachidonate 5-lipoxygenase , a i kapa ʻia hoʻi me ALOX5 , 5-lipoxygenase , 5-LOX , a i ʻole 5-LO , kahi enzyme non-heme iron-i loaʻa i loko o nā kānaka e ka encode ALOX5 . ʻO Arachidonate 5-lipoxygenase kahi lālā o ka ʻohana lipoxygenase o nā enzymes. Hoʻololi ia i nā mea momona momona (EFA) substrates i loko o nā leukotrienes a me ka laulā o nā huahana biologically ʻeleu. ʻO ALOX5 kahi pahuhopu i kēia manawa no ka hoʻopili lāʻau i loko o nā ʻano maʻi. | |
| 5-lipoxygenase-hoʻoulu i ka protein: ʻO ka protein Arachidonate 5-lipoxygenase-activating pū kekahi i ʻike ʻia ʻo 5-lipoxygenase activating protein , a ʻo FLAP , kahi protein i hoʻopili ʻia i nā kānaka e ka ʻāpana ALOX5AP . | |
| 5-lipoxygenase-hoʻoulu i ka protein: ʻO ka protein Arachidonate 5-lipoxygenase-activating pū kekahi i ʻike ʻia ʻo 5-lipoxygenase activating protein , a ʻo FLAP , kahi protein i hoʻopili ʻia i nā kānaka e ka ʻāpana ALOX5AP . | |
| 5M: E nānā paha ʻo 5M a i ʻole 5-M i:
| |
| 5-MBPB: ʻO 5-MBPB kahi kuhi amphetamine e pili pono ana i MDMA a ua kūʻai ʻia ma ke ʻano he lāʻau hoʻolālā. Hiki ke hoʻohālikelike ʻia ma ke ʻano he benzofuran-5-yl analogue o MBDB a i ʻole ka homologue butanamine o 5-MAPB, a he isomer hoʻolālā no 5-EAPB a me 6-EAPB. Hōʻike nā hōʻike Anecdotal ua kūʻai aku ʻia kēia hui ma ke ʻano he lāʻau hoʻolālā i nā ʻāina like ʻole o ʻEulopa mai ka wā mua o 2015, akā ʻo ka ʻike maopopo mua loa i hana ʻia i Kekemapa 2015 e kahi keʻena forensic ma Slovenia. | |
| 5-MAPB: ʻO 5-MAPB kahi lāʻau hoʻolālā entactogenic hoʻolālā like me MDMA i kāna ʻano a me nā hopena. | |
| 5-MAPDB: 5-MAPDB ( 1- (2,3-dihydrobenzofuran-5-yl) -N-methylpropan-2-amine ) kahi hui kemika e hana ma ke ʻano he lāʻau entactogenic. Pili pili ia i nā lāʻau e like me 5-APDB a me 5-MAPB, i loaʻa nā hopena like me MDMA a hoʻohana ʻia e like me nā lāʻau leʻaleʻa. Ua aʻo ʻia ʻo 5-MAPDB e hoʻoholo i kāna hana lāʻau, a ua ʻike ʻia he mea hoʻokuʻu serotonin i wae ʻia, ʻoiai me nā hana nāwaliwali ma ke ʻano he mea hoʻokuʻu i nā monoamines ʻē aʻe a me 5-HT 2 ʻohana agonist ʻohana, e like me nā hui kahiko e like me 5 APDB. | |
| 5-MAPDI: ʻO 5-MAPDI kahi mea entactogenic amphetamine derivative e pili pono ana i MDMA a me nā derivatives dihydrobenzofuran e like me 5-MAPDB a me 6-MAPDB, a ua kūʻai ʻia aku ma ke ʻano he lāʻau hoʻolālā. Ua kūʻai ʻia aku ma luna o nā pūnaewele mākeke-hina mai kahi o 2014, ʻoiai ʻaʻole i ʻike ʻia ka ʻike mua loa a hiki i Kepakemapa 2016 e kahi keʻena hoʻokolohua forensic ma Slovenia. | |
| 5-MBPB: ʻO 5-MBPB kahi kuhi amphetamine e pili pono ana i MDMA a ua kūʻai ʻia ma ke ʻano he lāʻau hoʻolālā. Hiki ke hoʻohālikelike ʻia ma ke ʻano he benzofuran-5-yl analogue o MBDB a i ʻole ka homologue butanamine o 5-MAPB, a he isomer hoʻolālā no 5-EAPB a me 6-EAPB. Hōʻike nā hōʻike Anecdotal ua kūʻai aku ʻia kēia hui ma ke ʻano he lāʻau hoʻolālā i nā ʻāina like ʻole o ʻEulopa mai ka wā mua o 2015, akā ʻo ka ʻike maopopo mua loa i hana ʻia i Kekemapa 2015 e kahi keʻena forensic ma Slovenia. | |
| 5-MeO-DMT: 5-MeO-DMT ( 5-methoxy- N , N -dimethyltr Egyptamine ) kahi psychedelic o ka papa tryptamine. ʻIke ʻia ia i nā ʻano mea kanu like ʻole, a ma ka liʻiliʻi he hoʻokahi ʻano toad, ka toad of the Desert Sonoran E like me kona ʻohana pili DMT a me bufotenin (5-HO-DMT), ua hoʻohana ʻia me he entheogen ma ʻAmelika Hema. Pākuʻi ʻia nā huaʻōlelo Slang me Five-methoxy, ka mana, a me Toad ʻona. | |
| 5-MeO-DMT: 5-MeO-DMT ( 5-methoxy- N , N -dimethyltr Egyptamine ) kahi psychedelic o ka papa tryptamine. ʻIke ʻia ia i nā ʻano mea kanu like ʻole, a ma ka liʻiliʻi he hoʻokahi ʻano toad, ka toad of the Desert Sonoran E like me kona ʻohana pili DMT a me bufotenin (5-HO-DMT), ua hoʻohana ʻia me he entheogen ma ʻAmelika Hema. Pākuʻi ʻia nā huaʻōlelo Slang me Five-methoxy, ka mana, a me Toad ʻona. | |
| 5-Methoxy-N, N-diisopropyltr Egyptamine: 5-Methoxy- N , N -diisopropyltr Egyptamine kahi psychedelic tryptamine a me ka methoxy i loaʻa mai o diisopropyltr Egyptamine (DiPT). | |
| 5-Methylmethiopropamine: ʻO ka 5-Methylmethiopropamine kahi lāʻau stimulant kahi mea i loaʻa i ke methiopropamine. ʻAʻole ia he kuhi cathinone pani e like me ka mephedrone, no ka mea nele i kahi hui ketone ma ke kūlana o ke kaulahao ʻaoʻao aliphatic, akā ʻoi aku ka like me nā amphetamines i pani ʻia. Ua kūʻai aku ʻia ma ke ʻano he lāʻau hoʻolālā, ʻike mua ʻia ma Kelemania i Iune 2020. | |
| 5-MBPB: ʻO 5-MBPB kahi kuhi amphetamine e pili pono ana i MDMA a ua kūʻai ʻia ma ke ʻano he lāʻau hoʻolālā. Hiki ke hoʻohālikelike ʻia ma ke ʻano he benzofuran-5-yl analogue o MBDB a i ʻole ka homologue butanamine o 5-MAPB, a he isomer hoʻolālā no 5-EAPB a me 6-EAPB. Hōʻike nā hōʻike Anecdotal ua kūʻai aku ʻia kēia hui ma ke ʻano he lāʻau hoʻolālā i nā ʻāina like ʻole o ʻEulopa mai ka wā mua o 2015, akā ʻo ka ʻike maopopo mua loa i hana ʻia i Kekemapa 2015 e kahi keʻena forensic ma Slovenia. | |
| 5-Methoxytr Egyptamine: ʻO 5-Methoxytr Egyptamine ( 5-MT ), i ʻike ʻia ʻo mexamine , kahi hua i loaʻa i ka tryptamine pili loa i nā neurotransmitters serotonin a me melatonin. Hōʻike ʻia ʻo 5-MT i kahi kūlohelohe i ke kino i nā pae haʻahaʻa. Hoʻokomo ʻia ia ma o ka deacetylation o melatonin i ka momona pineal. | |
| ʻO ka acid acid Levomefolic: ʻO ka waikawa Levomefolic (INN) (ʻo L-5-MTHF , L -methylfolate a me L -5-methyltetrahydrofolate a me (6 S ) -5-methyltetrahydrofolate , a me (6 S ) -5-MTHF ) ke ʻano hana biologically hana mua. o ka folate i hoʻohana ʻia i ka pae pae pūnaewele no ka hana hou ʻana o DNA, ka pōʻaiapuni cysteine a me ke kaohi o ka homocysteine. ʻO ia nō hoʻi ke ʻano i loaʻa i ke kaapuni a lawe ʻia ma waena o nā membrane i nāʻiʻo a ma o ka pale o ka lolo a me ka lolo. I ka pūnaewele, hoʻohana ʻia ʻo L-methylfolate i ka methylation o homocysteine e hana i ka methionine a me tetrahydrofolate (THF). ʻO THF ka mea i ʻae koke i hoʻokahi anakahi kalapona no ka synthesist o thymidine-DNA, nā purine (RNA a me DNA) a me ka methionine. ʻO ka un-methylated form, folic acid (wikamina B 9 ), kahi ʻano synthetic o folate, a pono e hana i ka hoʻēmi enzymatic e dihydrofolate reductase (DHFR) e lilo i biologically active. | |
| 5-Methyl-MDA: 5-Methyl-3,4-methylenedioxyamphetamine ( 5-Methyl-MDA ) kahi entactogen a me ka lāʻau hoʻolālā psychedelic o ka papa amphetamine. He homologue kani-methylated o MDA a me kahi isomer kūkulu o MDMA. | |
| 5, N-Dimethyl-N-isopropyltr Egyptamine: 5, N -Dimethyl- N -isopropyltr Egyptamine ( 5-Me-MiPT ) kahi pākana tryptamine i manaʻo ʻia he lāʻau psychedelic. Ua hana mua ʻia ia i ka makahiki 1989. Ua hōʻike nā in vitro binding hoʻokolohua ma ka homogenates lolo iā ia ka loaʻa ʻana o ka receptor serotonin ma waena o ka MiPT a me 5-MeO-MiPT, a ua ʻike ʻia nā psychedelics ʻeleu ʻelua i loko o nā kānaka. | |
| 5, N-Dimethyl-N-isopropyltr Egyptamine: 5, N -Dimethyl- N -isopropyltr Egyptamine ( 5-Me-MiPT ) kahi pākana tryptamine i manaʻo ʻia he lāʻau psychedelic. Ua hana mua ʻia ia i ka makahiki 1989. Ua hōʻike nā in vitro binding hoʻokolohua ma ka homogenates lolo iā ia ka loaʻa ʻana o ka receptor serotonin ma waena o ka MiPT a me 5-MeO-MiPT, a ua ʻike ʻia nā psychedelics ʻeleu ʻelua i loko o nā kānaka. | |
| 5-MeO-2-TMT: ʻO 5-Methoxy-2, N , N -trimethyltr Egyptamine kahi lāʻau psychoactive o ka papa hana kemika tryptamine e hana ma ke ʻano he psychedelic. Ua hana mua ʻia e Alexander Shulgin a hōʻike ʻia i kāna puke ʻo TiHKAL. Hōʻike ʻia ʻo 5-MeO-TMT e hōʻike i nā hopena psychoactive ma kahi mahele o 75-150 mg waha, akā he akahai kēia mau mea i hoʻohālikelike ʻia me nā ʻano hui like ʻē aʻe. Hōʻike kēia ʻoiai ʻo ka hui methyl ma ke kūlana 2 o ka mole i hōʻino ʻole i ka hoʻopaʻa ʻana o nā enzyme metabolic e like me monoamine oxidase (MAO), ke keʻakeʻa nei nō hoʻi me ka hoʻopaʻa ʻana a / a i ʻole ka hoʻoiho ʻana o ka serotonin 5-HT 2A receptor, ka pahuhopu kuleana no ka hoʻoponopono ʻana i nā hopena hallucinogenic o ia ʻano hui. | |
| 5-MeO-2-TMT: ʻO 5-Methoxy-2, N , N -trimethyltr Egyptamine kahi lāʻau psychoactive o ka papa hana kemika tryptamine e hana ma ke ʻano he psychedelic. Ua hana mua ʻia e Alexander Shulgin a hōʻike ʻia i kāna puke ʻo TiHKAL. Hōʻike ʻia ʻo 5-MeO-TMT e hōʻike i nā hopena psychoactive ma kahi mahele o 75-150 mg waha, akā he akahai kēia mau mea i hoʻohālikelike ʻia me nā ʻano hui like ʻē aʻe. Hōʻike kēia ʻoiai ʻo ka hui methyl ma ke kūlana 2 o ka mole i hōʻino ʻole i ka hoʻopaʻa ʻana o nā enzyme metabolic e like me monoamine oxidase (MAO), ke keʻakeʻa nei nō hoʻi me ka hoʻopaʻa ʻana a / a i ʻole ka hoʻoiho ʻana o ka serotonin 5-HT 2A receptor, ka pahuhopu kuleana no ka hoʻoponopono ʻana i nā hopena hallucinogenic o ia ʻano hui. | |
| 5-Methoxy-7, N, N-trimethyltr Egyptamine: 5-Methoxy-7, N, N-trimethyltr Egyptamine ( 5-MeO-7, N, N-TMT , 5-MeO-7-TMT ), he mea loaʻa mai ka tryptamine i hana ma ke ʻano he agonist ma nā mea loaʻa he 5-HT 2 serotonin. . I nā hoʻokolohua holoholona, ʻo 7, N, N-TMT a me 5-MeO-7, N, N-TMT i hana i nā pane e like me nā lāʻau psychedelic e like me DMT a me 5-MeO-DMT, akā hoʻohui pū me ka 7 kūlana nui. ʻo nā substituents e like me 7-ethyl-DMT a me 7-bromo-DMT ʻaʻole i hana i kahi kūpono kūpono psychedelic me ke ʻano he 5-HT 2 mea hoʻopaʻa paʻa paʻa, e ʻōlelo ana he mau antagonists a i ʻole nā agonists palupalu nāwaliwali no nā mea loaʻa he 5-HT 2 . ʻO ka hui e pili ana ʻo 7-MeO-MiPT (cf. 5-MeO-MiPT) ua ʻike ʻole ʻia e hana ʻole, e ʻōlelo ana he ʻae ʻole ka hoʻomanawanui ʻana i ke kūlana 7 no nā hui nui ma kēia kūlana, ma ka liʻiliʻi inā makemake ʻia ka hana agonist. | |
| 5-MeO-AET: 5-Methoxy-alpha-ethyltr Egyptamine ( 5-MeO-α-ET ) kahi lāʻau psychoactive a he lālā o ka papa kemika tryptamine. Hoʻopuka ia i nā psychedelic, entactogenic, a me nā hopena stimulant. | |
| MEAI: ʻO MEAI kahi lāʻau hoʻolauleʻa a me ka inu ʻana i ka inu inu binge, i hōʻike mua ʻia i kemika ma 1980, a i hōʻike mua ʻia i ka lāʻau i loko o kahi pepa i nānā ʻia e ka hoa ma 2017 e David Nutt et al. . Ma ka 2018, ua hoʻomaka kahi hui maʻAmelika Hui Pū ʻIa e hāʻawi i kahi mea inu MEAI i kapa ʻia ʻo "Pace". | |
| 5-MeO-aMT: 5-MeO-aMT a i ʻole 5-methoxy-α-methyltr Egyptamine , α, O-Dimethylserotonin ( Alpha-O ) kahi tryptamine psychedelic psychedelic ikaika. Hiki ke hoʻoheheʻe ʻia i ka etanol. | |
| Dimemebfe: ʻO Dimemebfe ( 5-MeO-BFE ) kahi lāʻau hoʻohauʻoli a me ka mea noiʻi noiʻi. Hana ia ma ke ʻano he agonist no ka ʻohana 5-HT 1A a me 5-HT 2 o nā serotonin receptor. Pili ia i ka hanana i ka psychedelic tryptamine derivative 5-MeO-DMT, akā me ka nitrogen indole i hoʻololi ʻia e oxygen, e hana ana i dimemebfe i kahi derivative benzofuran. ʻOi aku ka liʻiliʻi o ka mana ma ke ʻano he agonist serotonin ma mua o 5-MeO-DMT a me ka nui o ka hana ma 5-HT 1A , akā hōʻike mau i nā hopena ikaika ma ka ʻohana 5-HT 2 o nā mea loaʻa. | |
| 5-MeO-DALT: 5-MeO-DALT a i ʻole N, N -di allyl-5-methoxy tryptamine kahi tryptamine psychedelic i hana mua ʻia e Alexander Shulgin. | |
| 5-MeO-DET: 5-MeO-DET a i ʻole 5-methoxy- N, N -diethyltr Egyptamine kahi tryptamine hallucinogenic. | |
| 5-Methoxy-N, N-diisopropyltr Egyptamine: 5-Methoxy- N , N -diisopropyltr Egyptamine kahi psychedelic tryptamine a me ka methoxy i loaʻa mai o diisopropyltr Egyptamine (DiPT). | |
| 5-MeO-DMT: 5-MeO-DMT ( 5-methoxy- N , N -dimethyltr Egyptamine ) kahi psychedelic o ka papa tryptamine. ʻIke ʻia ia i nā ʻano mea kanu like ʻole, a ma ka liʻiliʻi he hoʻokahi ʻano toad, ka toad of the Desert Sonoran E like me kona ʻohana pili DMT a me bufotenin (5-HO-DMT), ua hoʻohana ʻia me he entheogen ma ʻAmelika Hema. Pākuʻi ʻia nā huaʻōlelo Slang me Five-methoxy, ka mana, a me Toad ʻona. | |
| 5-MeO-DPT: 5-MeO-DPT , kahi lāʻau psychedelic a entheogenic. | |
| 5-MeO-DALT: 5-MeO-DALT a i ʻole N, N -di allyl-5-methoxy tryptamine kahi tryptamine psychedelic i hana mua ʻia e Alexander Shulgin. | |
| 5-MeO-DiBF: ʻO 5-MeO-DiBF kahi psychedelic i kūʻai ʻia ma ka pūnaewele ma ke ʻano he lāʻau hoʻolālā a ʻike mua ʻia ia i ka lāʻo Dekemaba 2015 e kahi keʻena hoʻokolohua forensic ma Slovenia. Manaʻo ʻia e hana ma ke ʻano he agonist no ka ʻohana 5-HT 1A a me ka 5-HT 2 o nā serotonin receptor. Pili ia i ka hanana i ka psychedelic tryptamine derivative 5-MeO-DiPT, akā me ka nitrogen indole i hoʻololi ʻia e ka oxygen, e hoʻolilo ana iā 5-MeO-DiBF i kahi derzative benzofuran. ʻOi aku ka liʻiliʻi o ka mana ma ke ʻano he agonist serotonin ma mua o 5-MeO-DiPT a me ka nui o ka hana ma 5-HT 1A , akā hōʻike mau i nā hopena ikaika ma ka ʻohana 5-HT 2 o nā mea loaʻa. | |
| 5-Methoxy-N, N-diisopropyltr Egyptamine: 5-Methoxy- N , N -diisopropyltr Egyptamine kahi psychedelic tryptamine a me ka methoxy i loaʻa mai o diisopropyltr Egyptamine (DiPT). | |
| 5-MeO-EPT: ʻO 5-MeO-EPT kahi mea loaʻa psychedelic tryptamine derivative i kūʻai ʻia aku ma ke ʻano he lāʻau hoʻolālā. | |
| 5-MeO-EiPT: ʻO 5-MeO EiPT kahi psychedelic o ka papa tryptamine i kūʻai ʻia ma ka pūnaewele ma ke ʻano he lāʻau hoʻolālā. | |
| 5-MeO-MALT: ʻO 5-MeO-MALT ( 5-methoxy- N -methyl- N -allyltr Egyptamine ) kahi lāʻau psychedelic kaulana ʻole e pili loa ana i ka 5-MeO-DALT a ua kūʻai ʻia aku ma ka pūnaewele ma ke ʻano he lāʻau hoʻolālā. | |
| 5-MeO-MiPT: ʻO 5-MeO-MiPT kahi lāʻau psychedelic a me hallucinogenic, i hoʻohana ʻia e kekahi ma ke ʻano he entheogen. Loaʻa iā ia nā hanana a me nā lāʻau pharmacodynamic e like me nā lāʻau 5-MeO-DiPT, DiPT, a me MiPT. Hoʻohana mau ʻia ia ma ke ʻano he "mea pani" no 5-MeO-DiPT ma muli o ke ʻano like a me nā hopena. | |
| 5-MeO-MPMI: ʻO 5-MeO-MPMI kahi huahana tryptamine i loaʻa i kahi lāʻau psychedelic. Ua hoʻomohala mua ʻia e ka hui i alakaʻi ʻia e JE Macor ma 1992, a laila ua ʻimi ʻia e ka hui i alakaʻi ʻia e David Nichols mai ke Kulanui ʻo Purdue i ka hopena o 1990. Hoʻopuka kēia hui i ka pane kūpono i ka psychedelic i nā hoʻokolohua holoholona me ka mana e like me ka amphetamine i loaʻa i ka DOI psychedelic, a he ʻelua mau enantiomer, me ka ( R ) -enantiomer e hana nei. | |
| 5-MeO-MiPT: ʻO 5-MeO-MiPT kahi lāʻau psychedelic a me hallucinogenic, i hoʻohana ʻia e kekahi ma ke ʻano he entheogen. Loaʻa iā ia nā hanana a me nā lāʻau pharmacodynamic e like me nā lāʻau 5-MeO-DiPT, DiPT, a me MiPT. Hoʻohana mau ʻia ia ma ke ʻano he "mea pani" no 5-MeO-DiPT ma muli o ke ʻano like a me nā hopena. | |
| 5-MeO-NBpBrT: ʻO 5-MeO-NBpBrT kahi lālā i pani ʻia o ka ʻohana methoxytr Egyptamine o nā mea hoʻohui. E like me nā ʻano hui like ʻē aʻe e hana ia ma ke ʻano he antagonist no ka receptor 5-HT 2A , me kahi koho 100x i koi ʻia ma luna o ka mea loaʻa pono 5-HT 2C . ʻOiai ʻo N-benzyl pani o psychedelic phenethylamines e hopena pinepine i nā agonists 5-HT 2A ikaika , ua manaʻo ʻia e hōʻike ana nā tryptamines N-benzyl i ka hopena haʻahaʻa a nawaliwali paha nā agonists hapa a antagonists paha ma 5-HT 2A , ʻoiai ʻo ka noiʻi hou loa. ua hōʻike ʻoi aku ka ikaika o ka hana agonist no nā mea loaʻa 3-i loaʻa hou i benzyl. Ke hoʻonui nei i ka hui benzyl i kahi phenethyl pani e hiki ke hoʻihoʻi i ka hana agonist i kekahi mau hihia. | |
| 5-MeO-NMT: ʻO 5-MeO-NMT ( 5-methoxy- N -methyltr Egyptamine ) kahi hui kemika kūlohelohe , ʻo ia ka 5-methoxy analog o N -methyltr Egyptamine (NMT). Ua hoʻokaʻawale mua ʻia mai Phalaris arundinacea . Ua hana ʻia e Alexander Shulgin a hōʻike ʻia i kāna puke ʻo TiHKAL . E like me nā lālā ʻē aʻe o ka ʻohana N -methyltr Egyptamine o nā mea hoʻohui, manaʻo ʻia ʻo 5-MeO-NMT e hana i kekahi a i ʻole ʻole hopena psychedelic, ʻoiai he mea liʻiliʻi loa ka ʻike e pili ana i kāna pharmacological waiwai a i ʻole ka ʻawahia. | |
| 5-MeO-2-TMT: ʻO 5-Methoxy-2, N , N -trimethyltr Egyptamine kahi lāʻau psychoactive o ka papa hana kemika tryptamine e hana ma ke ʻano he psychedelic. Ua hana mua ʻia e Alexander Shulgin a hōʻike ʻia i kāna puke ʻo TiHKAL. Hōʻike ʻia ʻo 5-MeO-TMT e hōʻike i nā hopena psychoactive ma kahi mahele o 75-150 mg waha, akā he akahai kēia mau mea i hoʻohālikelike ʻia me nā ʻano hui like ʻē aʻe. Hōʻike kēia ʻoiai ʻo ka hui methyl ma ke kūlana 2 o ka mole i hōʻino ʻole i ka hoʻopaʻa ʻana o nā enzyme metabolic e like me monoamine oxidase (MAO), ke keʻakeʻa nei nō hoʻi me ka hoʻopaʻa ʻana a / a i ʻole ka hoʻoiho ʻana o ka serotonin 5-HT 2A receptor, ka pahuhopu kuleana no ka hoʻoponopono ʻana i nā hopena hallucinogenic o ia ʻano hui. | |
| 5-Methoxytr Egyptamine: ʻO 5-Methoxytr Egyptamine ( 5-MT ), i ʻike ʻia ʻo mexamine , kahi hua i loaʻa i ka tryptamine pili loa i nā neurotransmitters serotonin a me melatonin. Hōʻike ʻia ʻo 5-MT i kahi kūlohelohe i ke kino i nā pae haʻahaʻa. Hoʻokomo ʻia ia ma o ka deacetylation o melatonin i ka momona pineal. | |
| 5-MeO-aMT: 5-MeO-aMT a i ʻole 5-methoxy-α-methyltr Egyptamine , α, O-Dimethylserotonin ( Alpha-O ) kahi tryptamine psychedelic psychedelic ikaika. Hiki ke hoʻoheheʻe ʻia i ka etanol. | |
| 5-MeO-pyr-T: 5-MeO-pyr-T ( 5-methoxy- N , N -tetramethylenetryptamine ) kahi lāʻau psychedelic kaulana ʻole ʻike ʻia. ʻO ia ka analog 5-methoxy o pyr-T. Ua hana mua ʻia ʻo 5-MeO-pyr-T e Hunt & Brimblecombe, ka mea i hōʻoia iā S. Mitzal no ke ʻano o nā waiwai kemika. Ma hope mai ua hōʻike ʻia nā hōʻike kanaka e Alexander Shulgin, i kāna puke TiHKAL . Kuhi ʻia kahi mahele waha o 0.5 a 2 mg, a me kahi iniha inhaled o 2-3 mg. Hana ʻo 5-MeO-pyr-T i nā ʻano like ʻole, e like me ka amnesia, tinnitus, ka luaʻi, a me kahi ʻano hoʻoulu wikiwiki e like me 5-MeO-DMT. Ma ke kiʻina kiʻekiʻe i hōʻike ʻia ma TiHKAL, wehewehe ke kumuhana i ke ala ʻana mai kahi moku fugue i ka wā a lākou e auwana ana ma nā alanui, me ka amnesia piha ke ala aʻe. | |
| 5-MeO-AET: 5-Methoxy-alpha-ethyltr Egyptamine ( 5-MeO-α-ET ) kahi lāʻau psychoactive a he lālā o ka papa kemika tryptamine. Hoʻopuka ia i nā psychedelic, entactogenic, a me nā hopena stimulant. | |
| 5-MeO-aMT: 5-MeO-aMT a i ʻole 5-methoxy-α-methyltr Egyptamine , α, O-Dimethylserotonin ( Alpha-O ) kahi tryptamine psychedelic psychedelic ikaika. Hiki ke hoʻoheheʻe ʻia i ka etanol. | |
| 5-MeO-DMT: 5-MeO-DMT ( 5-methoxy- N , N -dimethyltr Egyptamine ) kahi psychedelic o ka papa tryptamine. ʻIke ʻia ia i nā ʻano mea kanu like ʻole, a ma ka liʻiliʻi he hoʻokahi ʻano toad, ka toad of the Desert Sonoran E like me kona ʻohana pili DMT a me bufotenin (5-HO-DMT), ua hoʻohana ʻia me he entheogen ma ʻAmelika Hema. Pākuʻi ʻia nā huaʻōlelo Slang me Five-methoxy, ka mana, a me Toad ʻona. | |
| 5-MeS-DMT: 5-MeS-DMT ( 5-methylthio- N , N -dimethyltr Egyptamine ) kahi lāʻau psychedelic kaulana ʻole ʻike ʻia. ʻO ia ka analog 5-methylthio o dimethyltr Egyptamine (DMT). 5-MeS-DMT i hana mua ʻia e Alexander Shulgin. I loko o kāna puke TiHKAL , helu ʻia ke ana palena iki ma 15-30 mg. ʻO ka lōʻihi i helu ʻia ma ke ʻano pōkole loa, e like me DMT. Hana ka 5-MeS-DMT i nā hopena like i DMT, akā nāwaliwali. Hōʻike ʻo Shulgin i kona mau manaʻo i ke kau haʻahaʻa o kēia lāʻau e like me ka "pōhaku kuhikuhi ʻole ʻia o ka pōhaku." | |
| 5-Methoxy-N, N-diisopropyltr Egyptamine: 5-Methoxy- N , N -diisopropyltr Egyptamine kahi psychedelic tryptamine a me ka methoxy i loaʻa mai o diisopropyltr Egyptamine (DiPT). | |
| 5-MeO-DMT: 5-MeO-DMT ( 5-methoxy- N , N -dimethyltr Egyptamine ) kahi psychedelic o ka papa tryptamine. ʻIke ʻia ia i nā ʻano mea kanu like ʻole, a ma ka liʻiliʻi he hoʻokahi ʻano toad, ka toad of the Desert Sonoran E like me kona ʻohana pili DMT a me bufotenin (5-HO-DMT), ua hoʻohana ʻia me he entheogen ma ʻAmelika Hema. Pākuʻi ʻia nā huaʻōlelo Slang me Five-methoxy, ka mana, a me Toad ʻona. | |
| 5-Methoxy-N, N-diisopropyltr Egyptamine: 5-Methoxy- N , N -diisopropyltr Egyptamine kahi psychedelic tryptamine a me ka methoxy i loaʻa mai o diisopropyltr Egyptamine (DiPT). | |
| 5-MeO-2-TMT: ʻO 5-Methoxy-2, N , N -trimethyltr Egyptamine kahi lāʻau psychoactive o ka papa hana kemika tryptamine e hana ma ke ʻano he psychedelic. Ua hana mua ʻia e Alexander Shulgin a hōʻike ʻia i kāna puke ʻo TiHKAL. Hōʻike ʻia ʻo 5-MeO-TMT e hōʻike i nā hopena psychoactive ma kahi mahele o 75-150 mg waha, akā he akahai kēia mau mea i hoʻohālikelike ʻia me nā ʻano hui like ʻē aʻe. Hōʻike kēia ʻoiai ʻo ka hui methyl ma ke kūlana 2 o ka mole i hōʻino ʻole i ka hoʻopaʻa ʻana o nā enzyme metabolic e like me monoamine oxidase (MAO), ke keʻakeʻa nei nō hoʻi me ka hoʻopaʻa ʻana a / a i ʻole ka hoʻoiho ʻana o ka serotonin 5-HT 2A receptor, ka pahuhopu kuleana no ka hoʻoponopono ʻana i nā hopena hallucinogenic o ia ʻano hui. | |
| 5-MeO-2-TMT: ʻO 5-Methoxy-2, N , N -trimethyltr Egyptamine kahi lāʻau psychoactive o ka papa hana kemika tryptamine e hana ma ke ʻano he psychedelic. Ua hana mua ʻia e Alexander Shulgin a hōʻike ʻia i kāna puke ʻo TiHKAL. Hōʻike ʻia ʻo 5-MeO-TMT e hōʻike i nā hopena psychoactive ma kahi mahele o 75-150 mg waha, akā he akahai kēia mau mea i hoʻohālikelike ʻia me nā ʻano hui like ʻē aʻe. Hōʻike kēia ʻoiai ʻo ka hui methyl ma ke kūlana 2 o ka mole i hōʻino ʻole i ka hoʻopaʻa ʻana o nā enzyme metabolic e like me monoamine oxidase (MAO), ke keʻakeʻa nei nō hoʻi me ka hoʻopaʻa ʻana a / a i ʻole ka hoʻoiho ʻana o ka serotonin 5-HT 2A receptor, ka pahuhopu kuleana no ka hoʻoponopono ʻana i nā hopena hallucinogenic o ia ʻano hui. | |
| 5-Methoxysalicylic acid: 5-Methoxysalicylic acid kahi hui kemika . He mahele o ka castoreum, ka exudate mai nā ʻeke castor o ka beaver makua. | |
| MMAI: 5-Methoxy-6-methyl-2-aminoindane ( MMAI ) kahi lāʻau i hoʻomohala ʻia i nā makahiki 1990 e kahi kime i alakaʻi ʻia e David E. Nichols ma ke Kulanui ʻo Purdue. Hana ia ma ke ʻano he neurotoxic non-selective a me ke koho koho nui (SSRA) a hoʻopuka i nā hopena entactogen i nā kānaka. Ua kūʻai ʻia aku ma ke ʻano he lāʻau hoʻolālā hoʻolālā a me ka noiʻi noiʻi kemika mai ka makahiki 2010. | |
| MMAI: 5-Methoxy-6-methyl-2-aminoindane ( MMAI ) kahi lāʻau i hoʻomohala ʻia i nā makahiki 1990 e kahi kime i alakaʻi ʻia e David E. Nichols ma ke Kulanui ʻo Purdue. Hana ia ma ke ʻano he neurotoxic non-selective a me ke koho koho nui (SSRA) a hoʻopuka i nā hopena entactogen i nā kānaka. Ua kūʻai ʻia aku ma ke ʻano he lāʻau hoʻolālā hoʻolālā a me ka noiʻi noiʻi kemika mai ka makahiki 2010. | |
| 5-Methoxy-7, N, N-trimethyltr Egyptamine: 5-Methoxy-7, N, N-trimethyltr Egyptamine ( 5-MeO-7, N, N-TMT , 5-MeO-7-TMT ), he mea loaʻa mai ka tryptamine i hana ma ke ʻano he agonist ma nā mea loaʻa he 5-HT 2 serotonin. . I nā hoʻokolohua holoholona, ʻo 7, N, N-TMT a me 5-MeO-7, N, N-TMT i hana i nā pane e like me nā lāʻau psychedelic e like me DMT a me 5-MeO-DMT, akā hoʻohui pū me ka 7 kūlana nui. ʻo nā substituents e like me 7-ethyl-DMT a me 7-bromo-DMT ʻaʻole i hana i kahi kūpono kūpono psychedelic me ke ʻano he 5-HT 2 mea hoʻopaʻa paʻa paʻa, e ʻōlelo ana he mau antagonists a i ʻole nā agonists palupalu nāwaliwali no nā mea loaʻa he 5-HT 2 . ʻO ka hui e pili ana ʻo 7-MeO-MiPT (cf. 5-MeO-MiPT) ua ʻike ʻole ʻia e hana ʻole, e ʻōlelo ana he ʻae ʻole ka hoʻomanawanui ʻana i ke kūlana 7 no nā hui nui ma kēia kūlana, ma ka liʻiliʻi inā makemake ʻia ka hana agonist. | |
| 5-MeO-DMT: 5-MeO-DMT ( 5-methoxy- N , N -dimethyltr Egyptamine ) kahi psychedelic o ka papa tryptamine. ʻIke ʻia ia i nā ʻano mea kanu like ʻole, a ma ka liʻiliʻi he hoʻokahi ʻano toad, ka toad of the Desert Sonoran E like me kona ʻohana pili DMT a me bufotenin (5-HO-DMT), ua hoʻohana ʻia me he entheogen ma ʻAmelika Hema. Pākuʻi ʻia nā huaʻōlelo Slang me Five-methoxy, ka mana, a me Toad ʻona. | |
| 5-Methoxy-N, N-diisopropyltr Egyptamine: 5-Methoxy- N , N -diisopropyltr Egyptamine kahi psychedelic tryptamine a me ka methoxy i loaʻa mai o diisopropyltr Egyptamine (DiPT). | |
| 5-MeO-DMT: 5-MeO-DMT ( 5-methoxy- N , N -dimethyltr Egyptamine ) kahi psychedelic o ka papa tryptamine. ʻIke ʻia ia i nā ʻano mea kanu like ʻole, a ma ka liʻiliʻi he hoʻokahi ʻano toad, ka toad of the Desert Sonoran E like me kona ʻohana pili DMT a me bufotenin (5-HO-DMT), ua hoʻohana ʻia me he entheogen ma ʻAmelika Hema. Pākuʻi ʻia nā huaʻōlelo Slang me Five-methoxy, ka mana, a me Toad ʻona. | |
| MMDMA: ʻO 5-Methoxy-3,4-methylenedioxymethamphetamine kahi lāʻau hoʻolālā no ka papa methylenedioxyphenethylamine (MDxx) i pani ʻia. ʻAʻoleʻike iki ʻia e pili ana i nā hopena a ʻaʻole i aʻo maʻamau ʻia i nā holoholona. | |
| 5-Methoxy-N, N-diisopropyltr Egyptamine: 5-Methoxy- N , N -diisopropyltr Egyptamine kahi psychedelic tryptamine a me ka methoxy i loaʻa mai o diisopropyltr Egyptamine (DiPT). | |
| 5-MeO-DMT: 5-MeO-DMT ( 5-methoxy- N , N -dimethyltr Egyptamine ) kahi psychedelic o ka papa tryptamine. ʻIke ʻia ia i nā ʻano mea kanu like ʻole, a ma ka liʻiliʻi he hoʻokahi ʻano toad, ka toad of the Desert Sonoran E like me kona ʻohana pili DMT a me bufotenin (5-HO-DMT), ua hoʻohana ʻia me he entheogen ma ʻAmelika Hema. Pākuʻi ʻia nā huaʻōlelo Slang me Five-methoxy, ka mana, a me Toad ʻona. | |
| 5-MeO-MPMI: ʻO 5-MeO-MPMI kahi huahana tryptamine i loaʻa i kahi lāʻau psychedelic. Ua hoʻomohala mua ʻia e ka hui i alakaʻi ʻia e JE Macor ma 1992, a laila ua ʻimi ʻia e ka hui i alakaʻi ʻia e David Nichols mai ke Kulanui ʻo Purdue i ka hopena o 1990. Hoʻopuka kēia hui i ka pane kūpono i ka psychedelic i nā hoʻokolohua holoholona me ka mana e like me ka amphetamine i loaʻa i ka DOI psychedelic, a he ʻelua mau enantiomer, me ka ( R ) -enantiomer e hana nei. | |
| 5-MeO-AET: 5-Methoxy-alpha-ethyltr Egyptamine ( 5-MeO-α-ET ) kahi lāʻau psychoactive a he lālā o ka papa kemika tryptamine. Hoʻopuka ia i nā psychedelic, entactogenic, a me nā hopena stimulant. | |
| 5-MeO-aMT: 5-MeO-aMT a i ʻole 5-methoxy-α-methyltr Egyptamine , α, O-Dimethylserotonin ( Alpha-O ) kahi tryptamine psychedelic psychedelic ikaika. Hiki ke hoʻoheheʻe ʻia i ka etanol. | |
| 5-Methoxy-N, N-diisopropyltr Egyptamine: 5-Methoxy- N , N -diisopropyltr Egyptamine kahi psychedelic tryptamine a me ka methoxy i loaʻa mai o diisopropyltr Egyptamine (DiPT). | |
| 5-MeO-DMT: 5-MeO-DMT ( 5-methoxy- N , N -dimethyltr Egyptamine ) kahi psychedelic o ka papa tryptamine. ʻIke ʻia ia i nā ʻano mea kanu like ʻole, a ma ka liʻiliʻi he hoʻokahi ʻano toad, ka toad of the Desert Sonoran E like me kona ʻohana pili DMT a me bufotenin (5-HO-DMT), ua hoʻohana ʻia me he entheogen ma ʻAmelika Hema. Pākuʻi ʻia nā huaʻōlelo Slang me Five-methoxy, ka mana, a me Toad ʻona. | |
| 5-MeO-aMT: 5-MeO-aMT a i ʻole 5-methoxy-α-methyltr Egyptamine , α, O-Dimethylserotonin ( Alpha-O ) kahi tryptamine psychedelic psychedelic ikaika. Hiki ke hoʻoheheʻe ʻia i ka etanol. | |
| 5-Methoxy-N, N-diisopropyltr Egyptamine: 5-Methoxy- N , N -diisopropyltr Egyptamine kahi psychedelic tryptamine a me ka methoxy i loaʻa mai o diisopropyltr Egyptamine (DiPT). | |
| 5-Methoxymethylone: ʻO 5-Methoxymethylone kahi hui kemika o ka cathinone papa i kūʻai ʻia aku ma ka pūnaewele ma ke ʻano he lāʻau hoʻolālā. ʻO ia ka mana beta-ketone o 5-Methoxy-MDMA. ʻO ka inoa ʻoi aku ka nui o 2-AIMP / 2-A1MP ʻaʻole i pili ka pilina mole. I ka hoʻohālikelike ʻana me ka methylone, ʻokoʻa nā hui ʻelua e ka hoʻohui o kahi hui methoxy ma ka 5th carbon atom o ke apo ʻaʻala. ʻAʻole ʻike ʻia ka ʻona o kēia hui. | |
| Bergapten: ʻO Bergapten ( 5-methoxypsoralen ) kahi hui kūlohelohe kūlohelohe i hana ʻia e nā ʻano mea kanu he nui, keu hoʻi mai ka ʻohana carrot Apiaceae a me ka ʻohana citrus Rutaceae. ʻO kahi laʻana, ua kāʻili ʻia ʻo bergapten mai nā ʻano 24 o ka genus Heracleum ma ka ʻohana Apiaceae. I ka ʻohana Rutaceae, loaʻa i nā ʻano Citrus like ʻole ka nui o nā bergapten, keu hoʻi i ka ʻalani bergamot, ka micrantha, a me kekahi mau ʻano lime a me ka ʻalani ʻawaʻawa. | |
| 5-Methoxysalicylic acid: 5-Methoxysalicylic acid kahi hui kemika . He mahele o ka castoreum, ka exudate mai nā ʻeke castor o ka beaver makua. | |
| 5-Methoxysalicylic acid: 5-Methoxysalicylic acid kahi hui kemika . He mahele o ka castoreum, ka exudate mai nā ʻeke castor o ka beaver makua. | |
| 5-Methoxytr Egyptamine: ʻO 5-Methoxytr Egyptamine ( 5-MT ), i ʻike ʻia ʻo mexamine , kahi hua i loaʻa i ka tryptamine pili loa i nā neurotransmitters serotonin a me melatonin. Hōʻike ʻia ʻo 5-MT i kahi kūlohelohe i ke kino i nā pae haʻahaʻa. Hoʻokomo ʻia ia ma o ka deacetylation o melatonin i ka momona pineal. | |
| MMAI: 5-Methoxy-6-methyl-2-aminoindane ( MMAI ) kahi lāʻau i hoʻomohala ʻia i nā makahiki 1990 e kahi kime i alakaʻi ʻia e David E. Nichols ma ke Kulanui ʻo Purdue. Hana ia ma ke ʻano he neurotoxic non-selective a me ke koho koho nui (SSRA) a hoʻopuka i nā hopena entactogen i nā kānaka. Ua kūʻai ʻia aku ma ke ʻano he lāʻau hoʻolālā hoʻolālā a me ka noiʻi noiʻi kemika mai ka makahiki 2010. | |
| 5-Methyl-7-methoxyisoflavone: ʻO 5-Methyl-7-methoxyisoflavone , i kapa maʻalahi ʻia ʻo methoxyisoflavone , kahi hui kemika i kūʻai ʻia ma ke ʻano he bodybuilding supplement. Eia nō naʻe, ʻaʻohe hōʻike pilikino kūpono e kākoʻo i kona pono. ʻO kahi noiʻi i paʻi ʻia ma 2006 i nānā i ka hopena o ka methoxyflavone i ka hoʻomaʻamaʻa hoʻomaʻamaʻa a me nā māka o ka anabolism muscle a me ka catabolism. ʻAʻole i ʻike ʻia nā hopena i ka hana haʻuki a i ʻole nā pae o ka testosterone a me ka cortisol. | |
| 5, N, N-TMT: 5, N , N - N -trimethyltr Egyptamine kahi pākana tryptamine kahi lāʻau psychedelic. Ua hana mua ʻia ia ma ka makahiki 1958 e EH Young. I nā hoʻokolohua holoholona ua ʻike ʻia aia ma waena o DMT a me 5-MeO-DMT i ka mana e hōʻike i kahi ana hana no nā kānaka ma ka pae 20-60 mg. Ua koi ʻia ka psychoactivity kanaka no kēia hui i nā hōʻike ma nā pūnaewele e like me Erowid akā ʻaʻole i hōʻoia kūʻokoʻa ʻia. | |
| 5-Methylethylone: ʻO 5-Methylethylone kahi emphogen, stimulant a me ka lāʻau psychedelic o ka amphetamine, phenethylamine, a me nā papa kemika cathinone. Pili ia ia i ka ethylone, kahi lāʻau hoʻolālā puke. Aia kahi ʻikepili liʻiliʻi e pili ana i nā waiwai lāʻau, metabolism, a me nā mea ʻona o 5-methylethylone, ʻoiai ua kūʻai ʻia aku ma ke ʻano he lāʻau hoʻolālā. | |
| 5-Methyl-MDA: 5-Methyl-3,4-methylenedioxyamphetamine ( 5-Methyl-MDA ) kahi entactogen a me ka lāʻau hoʻolālā psychedelic o ka papa amphetamine. He homologue kani-methylated o MDA a me kahi isomer kūkulu o MDMA. | |
| 5-Methylethylone: ʻO 5-Methylethylone kahi emphogen, stimulant a me ka lāʻau psychedelic o ka amphetamine, phenethylamine, a me nā papa kemika cathinone. Pili ia ia i ka ethylone, kahi lāʻau hoʻolālā puke. Aia kahi ʻikepili liʻiliʻi e pili ana i nā waiwai lāʻau, metabolism, a me nā mea ʻona o 5-methylethylone, ʻoiai ua kūʻai ʻia aku ma ke ʻano he lāʻau hoʻolālā. |
Thursday, March 18, 2021
5-Hydroxyeicosatetraenoic acid, 5-Hydroxyferulic acid, 5-Hydroxyhydantoin
Subscribe to:
Post Comments (Atom)
Barqan, Barkan Industrial Park, Baraqu
Barqan: E nānā paha ʻo Barqan ʻO Barkan, kahi noho Israel i ka West Bank ʻO Qasr-e Qand, kahi kūlanakauhale i ʻIrani Pāka ʻo Barkan I...
-
ʻO Sir Charles Dilke, 2nd Baronet: ʻO Sir Charles Wentworth Dilke, 2nd Baronet , he mea kālaiʻāina Pelekane Liberal a PC. ʻO kahi repu...
-
Arc ma Pā puni: ʻO Arc i Round kahi pāʻina ʻo Philadelphia, Pennsylvania i hoʻokumu ʻia e ka mea hoʻohana nui a me ka ʻenekini leo Jef...
-
Misisipi: Mississippi He He moku'āina i loko o ka Southeastern māhele o kaʻAmelika Hui Pūʻia, i kokoke i ke kukulu akau ma Tenness...
No comments:
Post a Comment